Skip to content

Safety Evaluation of Hyperperitoneal Chemotherapy in Elderly Patients With Serous Invasion of Colorectal Cancer - A Randomized Controlled Study

Safety Evaluation of Hyperperitoneal Chemotherapy in Elderly Patients With Serous Invasion of Colorectal Cancer - A Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099009
Enrollment
Unknown
Registered
2025-03-17
Start date
2022-11-14
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

HIPEC treatment group:Radical colorectal cancer resection+HOPEC(Mitomycin 30mg/m2+ 0.9%NS (2000 ml/m2 +500 ml),peritoneal perfusion,43°C,90 minutes)
Control group:Radical colorectal cancer resection

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=65 years; 2.ECOG Scores = 1.5 x 10^2/L, platelet >= 100 x 10^9/L, serum total bilirubin = 50 ml/min; 7. signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Occurrence of distant metastasis (such as liver metastasis, lung metastasis, para aortic lymph node metastasis, etc.); 2. Visible peritoneal metastasis, ovarian metastasis, or malignant ascites; 3. Rectal cancer below peritoneal reflection; 4. Recurrent colorectal cancer or primary colorectal cancer that has been resected; 5. Severe abdominal infection or extensive adhesions in the abdominal cavity form an unbreakable separation; 6. Emergency surgery for perforation, obstruction, etc; 7. Individuals with severe cardiovascular, vascular, mental illness, or substance abuse; 8. Allergic to chemotherapy drugs or related medications.

Design outcomes

Primary

MeasureTime frame
Postoperative complications and recovery;Routine blood,liver function and kidney function, electrolytes, CEA, CA199 after HIPEC;

Secondary

MeasureTime frame
Number of days in hospital;

Countries

China

Contacts

Public ContactTao Yu

Beijing Hospital

ytbjhmoh@163.com+86 139 1136 5751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026